Company page

Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated (CORT) is a publicly traded company based in the United States, with a market capitalization of approximately $10.24 billion. The company focuses on developing and commercializing innovative therapies for the treatment of various medical conditions. Corcept is committed to advancing its research and providing effective solutions for patients.